Filters
| Tests names and labs | Conditions | Genes and analytes | Methods |
|---|---|---|---|
Disorder of Sexual Development Screen (20 Genes + Molecular Karyotype) EVOLVEGENE EvolveGene United States | 49 | 22 |
|
Centogene AG - the Rare Disease Company Germany | 769 | 514 |
|
Centogene AG - the Rare Disease Company Germany | 769 | 514 |
|
Centogene AG - the Rare Disease Company Germany | 1 | 1 |
|
46,XX Disorders of Sex Development/Complete Gonadal Dysgenesis Deletion/Duplication Panel Genetic Services Laboratory University of Chicago United States | 9 | 9 |
|
46,XY Disorders of Sex Development/Complete Gonadal Dysgenesis Deletion/Duplication Panel Genetic Services Laboratory University of Chicago United States | 28 | 26 |
|
qGenEx Sex development disorders Quantitative Genomic Medicine Laboratories, SL Spain | 45 | 48 |
|
Exome PLUS Proteinuria/FSGS & Hematuria Laboratory for Molecular Medicine Partners HealthCare Personalized Medicine United States | 29 | 32 |
|
46,XX Disorders of Sex Development/Complete Gonadal Dysgenesis Sequencing Panel Genetic Services Laboratory University of Chicago United States | 8 | 8 |
|
PreventionGenetics United States | 26 | 19 |
|
Baylor Miraca Genetics Laboratories United States | 845 | 637 |
|
PreventionGenetics United States | 3 | 1 |
|
WT1-Related Disorders - Del/Dup Analysis Children's Hospital Colorado Molecular Genetics Laboratory Children's Hospital Colorado United States | 6 | 1 |
|
WT1-Related Disorders - Sequencing Children's Hospital Colorado Molecular Genetics Laboratory Children's Hospital Colorado United States | 6 | 1 |
|
Hereditary Cancer Syndrome: Deletion/Duplication Panel EGL Genetic Diagnostics Eurofins Clinical Diagnostics United States | 116 | 55 |
|
Eye Disorders: Deletion/Duplication Panel EGL Genetic Diagnostics Eurofins Clinical Diagnostics United States | 321 | 207 |
|
Disproportionate Short Stature: Deletion/Duplication Panel EGL Genetic Diagnostics Eurofins Clinical Diagnostics United States | 198 | 76 |
|
Denys-Drash syndrome (sequence analysis of WT1 gene) CGC Genetics Portugal | 1 | 1 |
|
Denys-Drash syndrome (sequence analysis of WT1 gene) CGC Genetics Portugal | 1 | 1 |
|
Laboratorio de Genetica Clinica SL Spain | 1 | 1 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.